It brings together researchers, regulators, industry experts, and academics to discuss drug safety, real-world evidence, and healthcare outcomes, with a strong focus on improving public health through data-driven research and collaboration.
The event is organized into two main parts:
- Pre-Conference Activities / Sessions – specialized workshops and focused scientific discussions
- Annual Meeting & Expo (29 August – 2 September 2026) – main scientific program including presentations, symposia, networking, and exhibition activities
Key Topics
- Pharmacoepidemiology & Drug Safety
- Real-World Evidence (RWE)
- Therapeutic Risk Management
- Regulatory Science & Policy
- Epidemiologic Methods & Study Design
- Pharmacovigilance Systems
- Health Outcomes Research
- Drug Utilization Studies
- Data Science in Healthcare
- Global Public Health & Medicines Safety
- Causal Inference & Methodology
- Risk–Benefit Assessment
- Healthcare Databases & Registries
- Emerging Methods in Real-World Data